per-chart, page-176

yes
But if you watched the podcast of Bianca Ogden from Platinum .. I posted last week .
Her biggest regret is “ selling too early “

1) we know the endpoints being PUL2.0
2) we have already achieved that
3) we are dosing at 25 mg and 50 mg
4)our results have already been published in reputable medical journals
5) Experienced Board with Commercialisation results
6)Money in the Bank
7) Tox study looking good
8) Boys in Turkey dosed for more than 9 months
9)No competitors in the inflammation space.
10) Meeting with the FDA re Tox and DMD Data in 4th 1/4 2024.

Everything : Just Fine